Biomedical Imaging Research Institute, Cedars Sinai Medical Center, 8700 Beverly Blvd., PACT Suite 400, Los Angeles, CA, 90048, USA.
Department of Radiology, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, China.
Curr Atheroscler Rep. 2017 Sep;19(9):37. doi: 10.1007/s11883-017-0672-z.
This short review summarizes the recent development in clinical and experimental imaging techniques for coronary atherosclerosis.
Coronary atherosclerosis is the underlying disease of myocardial infarction, the leading cause of death in the industrialized world. Conventional ways of risk assessment, including evaluation of traditional risk factors and interrogation of luminal stenosis, have proven imprecise for the prediction of major events. Rapid advances in noninvasive imaging techniques including MRI, CT, and PET, as well as catheter-based methods, have opened the doors to more in-depth interrogation of plaque burden, composition, and many crucial pathological processes such as inflammation and hemorrhage. These emerging imaging modalities and methodologies, combined with conventional imaging evidences of anatomy and ischemia, offer the promises to provide comprehensive information of the disease status. There is tremendous clinical potential for imaging to improve the current management of coronary atherosclerosis, including the identification of high-risk patients for aggressive therapies and guiding personalized treatment. In this review, we provide an overview of the state-of-the-art coronary plaque imaging techniques focusing on their respective strengths and weaknesses, as well as their clinical outlook.
本文简要综述了冠状动脉粥样硬化的临床和实验影像学技术的最新进展。
冠状动脉粥样硬化是心肌梗死的基础疾病,也是工业化国家死亡的主要原因。传统的风险评估方法,包括评估传统危险因素和管腔狭窄程度,已被证明对预测重大事件不够准确。包括 MRI、CT 和 PET 在内的非侵入性成像技术以及基于导管的方法的快速发展,为深入检查斑块负荷、成分以及炎症和出血等许多关键病理过程打开了大门。这些新兴的成像方式和方法,结合传统的解剖学和缺血影像学证据,有望提供有关疾病状况的全面信息。影像学在改善冠状动脉粥样硬化的当前治疗方面具有巨大的临床潜力,包括识别高危患者进行积极治疗和指导个体化治疗。在本文中,我们概述了冠状动脉斑块成像技术的最新进展,重点介绍了它们各自的优缺点及其临床前景。